Urocortins in the mammalian endocrine system

C Squillacioti, A Pelagalli, G Liguori… - Acta Veterinaria …, 2019 - Springer
Urocortins (Ucns), peptides belonging to the corticotropin-releasing hormone (CRH) family,
are classified into Ucn1, Ucn2, and Ucn3. They are involved in regulating several body …

The corticotropin releasing factor system in cancer: expression and pathophysiological implications

A Kaprara, K Pazaitou-Panayiotou, A Kortsaris… - Cellular and molecular …, 2010 - Springer
Malignant tumors express multiple factors that have some role in the regulating networks
supporting their ectopic growth. Recently, increased interest has been developing in the …

Fibronectin 1 protein expression in clear cell renal cell carcinoma

S Steffens, AJ Schrader, G Vetter… - Oncology …, 2012 - spandidos-publications.com
Abstract Fibronectin 1 (FN1) is a glycoprotein that is involved in cell adhesion and migration
processes including embryogenesis, wound healing, blood coagulation, host defenses and …

Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis

E Im, SH Rhee, YS Park, C Fiocchi, Y Taché… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: The corticotrophin-releasing hormone (CRH) family of peptides
modulates intestinal inflammation and the CRH receptor 2 (CRHR2) suppresses postnatal …

[HTML][HTML] Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling

JA Rodriguez, S Huerta-Yepez, IKM Law… - Cellular and …, 2015 - ncbi.nlm.nih.gov
Methods mRNA expression of CRH-family members was analyzed in CRC (N= 56) and
control (N= 46) samples, 7 CRC cell lines and normal NCM460 cells. Immunohistochemical …

Caveolin 1 protein expression in renal cell carcinoma predicts survival

S Steffens, AJ Schrader, H Blasig, G Vetter, H Eggers… - BMC urology, 2011 - Springer
Background Caveolae play a significant role in disease phenotypes such as cancer,
diabetes, bladder dysfunction, and muscular dystrophy. The aim of this study was to …

Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape

S Li, J Chen, X Chen, J Yu, Y Guo, M Li… - Frontiers in …, 2022 - frontiersin.org
Prostate cancer (PRAD) is a common and fatal malignancy. It is difficult to manage clinically
due to drug resistance and poor prognosis, thus creating an urgent need for novel …

Identification of a steroid hormone-associated gene signature predicting the prognosis of prostate cancer through an integrative bioinformatics analysis

YL Lai, CH Liu, SC Wang, SP Huang, YC Cho, BY Bao… - Cancers, 2022 - mdpi.com
Simple Summary Prostate cancer (PC) is the second most common cancer worldwide and
steroid hormone plays an important role in prostate carcinogenesis. Most patients with PC …

Corticotropin releasing hormone and urocortin 3 stimulate vascular endothelial growth factor expression through the cAMP/CREB pathway

SH Rhee, EL Ma, Y Lee, Y Taché, C Pothoulakis… - Journal of Biological …, 2015 - ASBMB
Colonic epithelium is the first line of defense against various pathological offenses in the gut.
Previous studies have shown that the peptides of the corticotropin-releasing hormone (CRH) …

[PDF][PDF] Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro

L Jin, Q Zhang, R Guo, L Wang, J Wang… - Journal of molecular …, 2011 - scholar.archive.org
Abstract Urocortin (Ucn), a corticotropin-releasing factor (CRF)-related neuropeptide binding
both CRF type 1 receptor (CRFR1) and CRFR2, has recently been found in prostate cancer …